IWC
RIGL icon

Integrated Wealth Concepts’s Rigel Pharmaceuticals RIGL Stock Holding History

Integrated Wealth Concepts’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,000
Closed -$10.8K – 1657
2023
Q3 		$10.8K Sell
1,000
-1,000
-50% -$12K ﹤0.01% 1551
2023
Q2 		$25.8K Buy
2,000
+1,000
+100% +$13.5K ﹤0.01% 1536
2023
Q1 		$13K Hold
1,000
– – ﹤0.01% 1331
2022
Q4 		$15K Buy
+1,000
New +$9.17K ﹤0.01% 1028

Other funds holding RIGL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Integrated Wealth Concepts's RIGL Position: Q4 2023 in Review

Integrated Wealth Concepts sold out of Rigel Pharmaceuticals (RIGL) in Q4 2023, closing a stake of 1,000 shares — an estimated $10.8K sold.

Integrated Wealth Concepts first reported a position in RIGL in Q4 2022 and held it in 4 quarters. The position peaked at $25.8K in Q2 2023. 112 funds tracked by Wall St. Rank hold RIGL as of Q4 2023.

  • Integrated Wealth Concepts reported no remaining Rigel Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Integrated Wealth Concepts sold 1,000 Rigel Pharmaceuticals shares in Q4 2023, an estimated $10.8K.
  • Integrated Wealth Concepts first reported a position in Rigel Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Integrated Wealth Concepts's Rigel Pharmaceuticals position peaked at $25.8K in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2023.

Based on Integrated Wealth Concepts's 13F filing for Q4 2023, filed 13 Feb 2024.